Medicines Company (MDCO) News

News for Medicines Company (MDCO)

After Hours: $ 20.75

0.00 (0.00%)

Volume: 345

4:50 PM EST Feb 10, 2012

Fri, Feb 03, 2012

4:15 PM

The Medicines Company to Announce Fourth Quarter and Full Year 2011 Financial Results on Wednesday, February 22, 2012 - Marketwire

Mon, Jan 23, 2012

7:30 AM

The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With App Pharmaceuticals - Marketwire

Tue, Jan 17, 2012

4:36 PM

The Medicines Company's Cangrelor Bridge Trial Published in the Journal of the American Medical Association - Marketwire

Thu, Dec 22, 2011

4:30 PM

The Medicines Company to Participate in the 30th Annual J.P. Morgan Healthcare Conference 2012 - Marketwire

Mon, Dec 05, 2011

8:00 AM

The Medicines Company Invests Equity Stake in GeNO, LLC, Nitric Oxide Delivery and Technology Company - Marketwire

Wed, Nov 30, 2011

4:30 PM

The Medicines Company to Participate in the 2011 Deutsche Bank BioFEST - Marketwire

Mon, Nov 14, 2011

4:31 PM

The Medicines Company's MDCO-216 (ApoA-I Milano Complex) Demonstrates Capacity to Clear Cholesterol From Cells in Preclinical Model - Marketwire

Sun, Nov 13, 2011

12:48 PM

German Researchers Reaffirm Utility of Angiomax(R)/Angiox(R) (Bivalirudin) in High Risk PCI Patients - Marketwire

Wed, Nov 09, 2011

3:50 PM

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT - Marketwire

Tue, Nov 08, 2011

3:42 PM

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT - Marketwire

Wed, Nov 02, 2011

4:30 PM

The Medicines Company Announces Schedule of Events at Upcoming Transcatheter Cardiovascular Therapeutics (TCT) Conference - Marketwire

Fri, Oct 28, 2011

9:00 AM

For Immediate Release to US Investors: The Medicines Company and Daiichi Sankyo Announce Angiox(R) (Bivalirudin) Co-Promotion for Germany - Marketwire

Wed, Oct 26, 2011

8:02 AM

The Medicines Company Reports Third Quarter 2011 Results - Marketwire

Sat, Oct 15, 2011

1:00 PM

The Medicines Company's MDCO-2010 Meets Clinical Trial Objectives in Patients Undergoing Open-Heart Surgery - Marketwire

Wed, Oct 12, 2011

4:30 PM

The Medicines Company to Announce Third Quarter 2011 Financial Results on Wednesday, October 26, 2011 - Marketwire

Mon, Oct 03, 2011

11:00 AM

The Medicines Company Launches New Formulation of Cleviprex(R) (Clevidipine) Injectable Emulsion - Marketwire

6:30 AM

The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva - Marketwire

Thu, Sep 22, 2011

4:30 PM

The Medicines Company to Participate in the Jefferies 2011 Global Healthcare Conference in London - Marketwire

Wed, Sep 14, 2011

4:30 PM

The Medicines Company to Participate in the UBS Global Life Sciences Conference - Marketwire

Mon, Sep 12, 2011

8:00 AM

The Medicines Company Launches 50mL Ready-to-Use Formulation of Argatroban Injection - Marketwire

Thu, Jul 28, 2011

4:30 PM

The Medicines Company Appoints Glenn P. Sblendorio to Board of Directors - Marketwire

Wed, Jul 27, 2011

8:00 AM

The Medicines Company Reports Second Quarter and First Half 2011 Results - Marketwire

Tue, Jul 26, 2011

8:30 PM

NICE Endorses Bivalirudin for Heart Attack Patients - Marketwire

Wed, Jul 13, 2011

4:30 PM

The Medicines Company to Announce Second Quarter 2011 Financial Results on Wednesday, July 27, 2011 - Marketwire

Tue, May 31, 2011

4:30 PM

The Medicines Company to Participate in the Jefferies 2011 Global Healthcare Conference - Marketwire

First

1 2

Last